Registered in Wenjiang, Chengdu in 2005, AstaTech (Chengdu)Biopharmaceutical Corp. (“AstaTech”) enterprise dedicated to CRO, CDMO,CMO,CMC and Process Safety Evaluation services for global pharmaceutical companies in small molecule drug intermediates. AstaTech has 12000-square-meter R&D labs and a kilo laboratory, with close to 420 employees, including more than 200 chemists, among which 16 are Ph.Ds.

After nearly 20 years of development, AstaTech has provided thousands of worldwide customers with advanced API intermediates from Pre-clinic stage scale. Phase I, Phase II ,Phase III to Commercial scale and tens of thousands of novel advanced intermediates for drug discovery; AstaTech has established a full-fledged production system which caters to small-scale, pilot-scale and commercial manufacturing; process R&D teams for API and special chemicals; with ISO9001 Quality Management System, ISO14001 International Environmental Management Certification System and ISO45001 Occupational Health Management System . AstaTech has 64 patents, including 55 inventions and 9 utility models.

AstaTech has more than 1000 global customers, including the top 30 global pharmaceutical companies in Europe, the U.S, Canada, Japan, Korea, India, China and other countries.

To provide reliable CDMO services to customers in a long term, AstaTech has multiple manufacturing sites in China, including Guang’an , Yibin Site in Sichuan, and Jinchang Site in Gansu which will be ready to operate in 2022.

AstaTech has been granted as Innovation & PracticeBase for Postdoctors, Academician (Expert) Innovation Workstation and Sichuan Provincial Enterprise Technology Center, and Top Innovation and Entrepreneurship Team of Sichuan“Thousand-talent Program”.

With“Integrity, Enterprising, Quality and Co-prosperity”as core value, we are customer-oriented and innovative, and in constant pursuit of excellence. We strive to be a global outstanding enterprise in the design, development and manufacture of high-quality functional molecular units.